Search Results - "CAMARA, Oumar"

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups by UNTCH, Michael, FASCHING, Peter A, STICKELER, Elmar, HARBECK, Nadia, HÖSS, Cornelia, KAHLERT, Steffen, BECK, Thomas, FETT, Werner, MEHTA, Keyur M, VON MINCKWITZ, Gunter, LOIBL, Sibylle, KONECNY, Gottfried E, HASMÜLLER, Stephan, LEBEAU, Annette, KREIENBERG, Rolf, CAMARA, Oumar, MÜLLER, Volkmar, DU BOIS, Andreas, KÜHN, Thorsten

“…To evaluate efficacy and safety of epirubicin and cyclophosphamide followed by paclitaxel and trastuzumab as neoadjuvant treatment in patients with human…”
Get full text

Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse by PACHMANN, Katharina, CAMARA, Oumar, RABENSTEIN, Carola, PACHMANN, Ulrich, RUNNEBAUM, Ingo, HÖFFKEN, Klaus, KAVALLARIS, Andreas, KRAUSPE, Sabine, MALARSKI, Nele, GAJDA, Mieczyslaw, KROLL, Torsten, JÖRKE, Cornelia, HAMMER, Ulrike, ALTENDORF-HOFMANN, Annelore

“…To demonstrate that it is possible to monitor the response to adjuvant therapy by repeated analysis of circulating epithelial tumor cells (CETCs) and to detect…”
Get full text

Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions by Baltzer, Pascal A. T., Benndorf, Matthias, Dietzel, Matthias, Gajda, Mieczyslaw, Camara, Oumar, Kaiser, Werner A.

“…Objective This study was performed to assess the sensitivity and specificity for malignant and benign mass lesions of a diagnostic approach combining DWI with…”
Get full text

Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group by SEHOULI, Jalid, STENGEL, Dirk, LICHTENEGGER, Werner, OSKAY-OEZCELIK, Guelten, ZEIMET, Alain G, SOMMER, Harald, KLARE, Peter, STAUCH, Martina, PAULENZ, Axel, CAMARA, Oumar, KEIL, Elke

“…The management of recurrent ovarian cancer remains controversial. Single-agent topotecan is an established treatment option, and preliminary evidence suggests…”
Get full text

High depletion of breast cancer cells from the peripheral blood with the method of non-specific separation by Payer, Petra, Röder, Michael, Camara, Oumar, Pachmann, Katharina

“…Circulating epithelial tumour cells (CETCs) play an important role in the formation of metastases in breast cancer patients. The depletion of such CETCs from…”
Get full text

Controversies in the Management of Ovarian Cancer - Pros and Cons for Lymph Node Dissection in Ovarian Cancer by CAMARA, Oumar, SEHOULI, Jalid

“…Up-front maximal surgical effort towards cytoreduction with the primary goal of maximum tumour resection is one of the cornerstones in the multimodal…”
Get full text

Sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-Mammography considering 974 histologically verified lesions by Baltzer, Pascal A T, Yang, Fan, Dietzel, Matthias, Herzog, Aimée, Simon, Anke, Vag, Tibor, Gajda, Mieczyslaw, Camara, Oumar, Kaiser, Werner Alois

“…The objective of this investigation was to determine the diagnostic value of unilateral edema in differentiating benign from malignant breast disease on…”
Get more information

Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study by Renz, Diane M., Baltzer, Pascal A. T., Böttcher, Joachim, Thaher, Fady, Gajda, Mieczyslaw, Camara, Oumar, Runnebaum, Ingo B., Kaiser, Werner A.

“…The aim of this study was to evaluate the potential of magnetic resonance mammography (MRM) to distinguish inflammatory breast carcinomas (IBC) from acute…”
Get full text

Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer by Baltzer, Pascal A. T., Vag, Tibor, Dietzel, Matthias, Beger, Sebastian, Freiberg, Christian, Gajda, Mieczyslaw, Camara, Oumar, Kaiser, Werner A.

“…Objective To perform a semiautomated software-based comparison of invasive breast carcinoma dynamic enhancement patterns in MR mammography with histological…”
Get full text

Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells by Camara, Oumar, Kavallaris, Andreas, Nöschel, Helmut, Rengsberger, Matthias, Jörke, Cornelia, Pachmann, Katharina

“…Surgery of malignant tumors has long been suspected to be the reason for enhancement of growth of metastases with fatal outcome. This often prevented surgeons…”
Get full text

Is “Prepectoral Edema” a Morphologic Sign for Malignant Breast Tumors? by Kaiser, Clemens G., MD, BA, Herold, Michael, MD, Baltzer, Pascal A.T., MD, Dietzel, Matthias, MD, Krammer, Julia, MD, Gajda, Mieczyslaw, MD, Camara, Oumar, MD, Schoenberg, Stefan O., MD, PhD, Kaiser, Werner A., MD, PhD, Wasser, Klaus, MD

“…Rationale and Objectives A variety of morphologic and kinetic signs of benign or malignant breast lesions contribute to a final diagnosis and differential…”
Get full text

Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring by Pachmann, Katharina, Camara, Oumar, Kavallaris, Andreas, Schneider, Uwe, Schünemann, Stefanie, Höffken, Klaus

“…In adjuvant treatment for breast cancer there is no tool available with which to measure the efficacy of the therapy. In contrast, in neoadjuvant therapy…”
Get full text

The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1,084 histologically verified cases by Dietzel, Matthias, Baltzer, Pascal A T, Vag, Tibor, Herzog, Aimee, Gajda, Mieczyslaw, Camara, Oumar, Kaiser, Werner A

“…The adjacent vessel sign (AVS) is a descriptor for differentiating malignant from benign breast lesions on breast MRI (bMRI). This investigation was designed…”
Get full text

Ultrasound-Guided, Percutaneous Cryotherapy of Small (≤15 mm) Breast Cancers by Pfleiderer, Stefan O. R, Marx, Christiane, Camara, Oumar, Gajda, Mieczyslaw, Kaiser, Werner A

“…RATIONALE AND OBJECTIVE:The purpose of this study was to investigate the feasibility, efficacy, and safety of ultrasound-guided percutaneous cryotherapy of…”
Get full text

Application of Computer-aided Diagnosis (CAD) in MR-Mammography (MRM) by Baltzer, Pascal Andreas Thomas, MD, Renz, Diane M., MD, Kullnig, Petra E., MD, Gajda, Mieczyslaw, MD, Camara, Oumar, MD, Kaiser, Werner A., MD, MS

“…Rationale and Objectives The identification of the most suspect enhancing part of a lesion is regarded as a major diagnostic criterion in dynamic magnetic…”
Get full text

Clinical MR-Mammography by Baltzer, Pascal Andreas Thomas, MD, Freiberg, Christian, MD, Beger, Sebastian, MD, Vag, Tibor, MD, PhD, Dietzel, Matthias, MD, Herzog, Aimee B., MD, Gajda, Mieczyslaw, MD, Camara, Oumar, MD, Kaiser, Werner A., MD, MS

“…Rationale and Objectives Enhancement characteristics after administration of a contrast agent are regarded as a major criterion for differential diagnosis in…”
Get full text

Inflammatory Breast Carcinoma in Magnetic Resonance Imaging by Renz, Diane M., MD, Baltzer, Pascal A.T., MD, Böttcher, Joachim, MD, Thaher, Fady, MD, Gajda, Mieczyslaw, MD, Camara, Oumar, MD, Runnebaum, Ingo B., MD, Kaiser, Werner A., MD, MS

“…Rationale and Objectives Although inflammatory breast carcinoma (IBC) accounts for 1%–4% of all breast cancer cases, the appearance of this highly malignant…”
Get full text

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial by Chekerov, Radoslav, Hilpert, Felix, Mahner, Sven, El-Balat, Ahmed, Harter, Philipp, De Gregorio, Nikolaus, Fridrich, Claudius, Markmann, Susanne, Potenberg, Jochem, Lorenz, Ralf, Oskay-Oezcelik, Guelten, Schmidt, Marcus, Krabisch, Petra, Lueck, Hans-Joachim, Richter, Rolf, Braicu, Elena Ioana, du Bois, Andreas, Sehouli, Jalid, Lichtenegger, Werner, Yalcinkaya, Isil, Kittner, Marion, Konwert, Ellen, Keller, Maren, Mustea, Alexander, Koensgen-Mustea, Dominique, Pietzner, Klaus, Camara, Oumar, Wimberger, Pauline, Elser, Gabriele, Polleis, Sandra

“…Antiangiogenic therapy has known activity in ovarian cancer. The investigator-initiated randomised phase 2 TRIAS trial assessed the multi-kinase inhibitor…”
Get full text

How to break bad news and how to learn this skill: results from an international North-Eastern German Society for Gynecological Oncology (NOGGO) survey among physicians and medical students with 1089 participants by Herzog, Emilie M, Pirmorady Sehouli, Adak, Boer, Jolijn, Pietzner, Klaus, Petru, Edgar, Heinzelmann, Viola, Roser, Eva, Dimitrova, Desislava, Oskay-Özcelik, Gülten, Camara, Oumar, Sehouli, Jalid

“…Delivering bad news to patients is one of the most challenging tasks in medical practice. Despite its great relevance to patients, relatives, and medical…”
Get more information

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments by Dufies, Maeva, Grytsai, Oleksandr, Ronco, Cyril, Camara, Oumar, Ambrosetti, Damien, Hagege, Anaïs, Parola, Julien, Mateo, Lou, Ayrault, Marion, Giuliano, Sandy, Grépin, Renaud, Lagarde, Nathalie, Montes, Matthieu, Auberger, Patrick, Demange, Luc, Benhida, Rachid, Pagès, Gilles

“…Clear cell Renal Cell (RCC) and Head and Neck Squamous Cell Carcinomas (HNSCC) are characterized by a pro-angiogenic/pro-inflammatory context. Despite…”
Get full text